Vladimir P. Torchilin is a University Distinguished Professor and Director, Center for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University, Boston. He graduated from the Moscow University with MS in Chemistry, and obtained there his Ph.D. and D.Sc. in Polymer Chemistry and Chemistry of Physiologically Active Compounds in 1971 and 1980, respectively. In 1991, Dr. Torchilin joined MGH/Harvard Medical School as the Head of Chemistry Program, Center for Imaging and Pharmaceutical Research, and Associate Professor of Radiology. Since 1998 Dr. Torchilin is with Northeastern University. He was the Chair of the Department of Pharmaceutical Sciences in 1998-2008. His research interests include liposomes, lipid-core micelles, biomedical polymers, drug delivery and targeting, pharmaceutical nanocarriers, experimental cancer immunology.

Welcome to the Wishart Research Group home page. Dr. David Wishart (PhD Yale, 1991) is a Professor in the Departments of Biological Sciences and Computing Science at the University of Alberta. He is also a senior research officer and the director of the Nano Life Science program at the NRC’s National Institute for Nanotechnology (NINT). He has been with the University of Alberta since 1995. Dr. Wishart has active research programs in structural biology, nanobiology, synthetic biology, prion biology, bioinformatics and metabolomics. Some of his lab's most significant contributions have been in the area of protein chemical shift analysis and the prediction of protein structure. Dr. Wishart has directed a number of core labs at the U of A over the years including the Faculty of Pharmacy's mass spectrometry core (from 1998-2002), the Polyomx bioinformatics core (2001-2004), the PENCE bioinformatics core facility (2002-2005) and the Genome Canada Bioinformatics Help Desk (2003-2011). From 2006-2009, Dr. Wishart led the Human Metabolome Project (HMP), a multi-university, multi-investigator project that catalogued all of the known metabolites in human tissues and biofluids. Using advanced methods in NMR spectroscopy, mass spectrometry, multi-dimensional chromatography and machine learning Dr. Wishart and his colleagues identified or found evidence for more than 8000 endogenous metabolites. This information has been archived on a freely accessible web-resource called the Human Metabolome Database.

Prof Selwood's research focuses on a chemical biology approach to molecular interactions. He has worked in pharma, in biotech and academia. In pharma he worked on the successful anti-migraine drug zolimitriptan (over $1 billion dollars in sales), also invented GW4991W93 a compound which completed phase 2 clinical trials. The CNS drug theme continued with work in academia on sodium channel blockers for neurodegeneration in multiple sclerosis (MS). MS has become a major theme with the discovery of a potassium channel activator (VSN16R) as a potential treatment for MS related spasticity and Fragile X. Another research theme is the study of neuropilin-1 in the vascular and immune system. With links to immune activation neuropilin-1 is relevant to the progression of MS and is an anti-cancer target. The impact of small molecules on the immune system has become a recent research focus with my work on neuropilin-1, and cyclophilin related innate immune signalling.

Dr. Tejraj Aminabhavi obtained his Ph.D (1979) from the University of Texas at Austin, Texas, USA. During 1980-2002, he was a professor of Physical Chemistry and in 2002-2007, the founder Director of Center of Excellence in Polymer Science at Karnatak University, Dharwad. During 2007-2012, he was the scientific advisor to Reliance Life Sciences, Navi Mumbai. Dr. Aminabhavi was a visiting professor at universities in USA, Taiwan, Korea, Cambridge (UK) and France. Dr. Aminabhavi is presently the Emeritus Fellow sponsored by All India Council for Technical Education, New Delhi, India (2012-2014) and is the Research Director at Soniya College of Pharmacy. Dr. Aminabhavi has been serving as the international advisory board member of Journal of Applied Polymer Science, Wiley Inter-Science, New York, USA since1998, Polymer Plastics Technology & Engineering, Marcel Dekker, New York, USA since 2000 and Column Editor, Polymer News, Gordon Breach, New York, USA (1997-2006). Presently, he is the Associate Editor of Chemical Engineering Journal (Elsevier, New York, USA). Dr. Aminabhavi has published 600 scientific papers including authoritative reviews in addition to three US patents on water desalination technologies and four Indian patents on drug delivery. He has supervised over 40 doctoral students and published a book on “Introduction to Macromolecular Science” (Wiley, New York, 2002). Dr. Aminabhavi’s research interests are in areas of molecular transport, membrane-based separations, pervaporation, gas separation, electrodialysis, micro, ultra and nanofiltration and reverse osmosis water technologies, controlled release polymeric devices, micro/nanoparticles, transdermal patches and hydrogels for drugs, proteins, peptides, genes, pesticides and polymer-drug conjugates. Molecular modelling on polymeric surfaces, prediction of polymer blend compatibility, drug diffusion and gas transport, polyurethane coatings, polymer composites, dendrimers, heat resistant and conducting polymers, liquid state properties and polymer solution theories.

Dr Alex Barker is a Research Associate within the Musculoskeletal Biology Research Laboratory, led by A/Prof. Paul Anderson at the University of South Australia. Dr. Barker completed her PhD in Medicine at the University of Adelaide in 2019, where she investigated novel bone agents that could improve the rate of bone repair. This work included assessing the agents in both in vitro and pre-clinical models. Dr. Barker is now currently working on an industry collaboration project, to test whether mimicking the nano-spike surface topography found on the wings of insects, which have inherent antimicrobial characteristics, on orthopaedic implants can kill harmful bacteria that cause infections.

My group studies the secondary metabolites (natural products) produced by marine and terrestrial microorganisms to probe their unmatched therapeutic and biological tool potential. Our research deciphers the function based microbial chemical diversity and work towards connecting the biosynthetic gene clusters to the elucidated new/known chemical entities by utilizing state-of-the-art technologies in UM Natural Products Discovery Core. Natural products have been invaluable as platforms for developing front-line drugs against cancer, infectious diseases, parasites, and as probes in cellular biology, biochemistry, chemical genetics. A survey of all 246 FDA approved antitumor drug between late 1940’s to 2014 shows that >65% of those are either natural products or are modified form of natural products, indicating the overwhelming success of NPs in the human pharmacopeia. A closer observation reveals further interesting facts that marine natural product discovery, which is relatively a recent phenomenon has yielded approximately one drug per 4025 marine natural products (MNPs) isolated which is 1.2-2.5-fold better then industry average (1 in 5000-10000 compounds). The U-M Natural Products Discovery Core has developed a 45,000-sample (and growing) library of natural product extracts derived from a unique collection of diverse marine and terrestrial actinomycetes, fungi and cyanobacteria. The core provides researchers at U-M and external partners with the technology and expertise to develop candidates identified through high-throughput screening into unique, bioactive, patentable, small molecules and commercially viable enzymes.

Marco Milanese is Associate Professor at the Department of Pharmacy of the University of Genoa. Since 2006 the scientific interest of M. Milanese focuses on various aspects of neurotransmission and molecular mechanisms involved in neurodegenerative processes; the research activity of M. Milanese is characterised by the study of glutamatergic neurotransmission linked to excitotoxicity in neurodegenerative diseases, with particular interest to amyotrophic lateral sclerosis (ALS). The current research lines of M. Milanese are aimed at studying the etiopathological mechanisms of ALS and develop translational strategies, by exploiting in-vivo behavioural analysis on experimental mouse models of ALS, as well as biochemical and functional in-vitro studies on motoneuron, astrocyte, microgliaand oligodendrocyte primary cell cultures.In this framework, very recently, M. Milanese demonstrated the pivotal role of different receptors expressed at the CNS supporting the progression of ALS pathology, paving the way for new therapeutic approach to counteract MN degeneration in ALS. M. Milanese holds active scientific collaborations with National and International research groups, as intelligible from the publication track record.

Dr. Sandeep Arora is a seasoned Pharma and Academic professional with an experience spanning over 27 years in Pharma operations, Quality management, academics, training, research & consultancy planning and administration. Being an avid researcher and writer, he has three books, 18 patents, 120 research publications (h index 17), 3 books, 4 Trademarks and one registered company to his credit. For his team, innovation, administrative, quality and coordination skills, he is elected member of (APTI) Pharmacy Council of India, Association of Pharmaceutical Teachers of India, and Indian Pharma Association (IPA), and has offered valued and committed support towards the functions of these organizations, as an extended service to the Pharmaceutical, Healthcare and Lifestyle industry. He represents the Qualitative vision and Mission of Chitkara University and its various campuses, for delivering academic, research, innovation and social excellence, as Prof & Director, Pharma Sciences. As an academician, he is known for initiation and advancements of Pharma institutes of excellence in academics and research and has been eminent member in various Committee including University Affairs, Examination, Evaluation and PhD committees of Indian and International Universities and has delivered sessions as expert/key note speaker and Chair at many International Conferences and Universities on various topics relevant to Pharmaceutical industry trends, technology, Phytopharmaceuticals, regulatory affairs. Some of the prominent ones include those for University of Florida, Pfizer-IPA CPD Sessions, OMICS and Conference Series Conferences at Thailand. As a consultant, he has offered solutions in the areas Phytopharmaceuticals Development, Standardization, Biological activity and Regulatory Affairs and market support to many industries. He is President (R & D) Natural Solutions, Mumbai, Advisor, Pharexcel Consulting, Scientific Advisor, AMulya Herbs, Panchkula. He has a flair for technical, social and general writing and playing musical instruments including flute, Harmonica and percussion instruments.

Dr. Shital Butani has 19 years of total experience in teaching, industry and research. She worked as Sr. Research Scientist at Formulation and Development Department for regulatory market (ANDA filling in USFDA) in Cadila HealthCare Pvt. Ltd., Ahmedabad. She received ‘Project Excellence’ award for one of the formulation during her tenure in Cadila. She has published 35 papers in reputed international and national journals and presented more than thirty five papers in various national and international seminars. She played volley ball upto national level during her schooling. She is recognized post graduate faculty and Ph. D. Guide at Institute of Pharmacy, Nirma University. She has guided twenty five M. Pharm students, 5 Ph D. students. She has received best paper award (Pharmaceutics) from Indian drug manufacturers association (IDMA). She has received minor research grant from Gujarat Council on Science & Technology (GUJCOST) worth Rs. 3,60,000/- and travel grant from DST, India for attending conference of Lisbon, Portugal. She also received Major research project worth Rs. 21 lacs from IPR-BRNS. She is felicitated in year 2014 and 2015 during foundation day at Institute of Pharmacy, Nirma University. She was invited to deliver invited talk in various programs as well as to evaluated research work of M Pharm and Ph D students at various Institutes. Her area of research includes solubility enhancement, pulmonary drug delivery systems, controlled release formulations and nanoparticulate drug delivery systems.

Dr.Bhupendra works as Professor in Department of Pharmaceutics, Shree S.K.Patel College of Pharmaceutical Education and Research, Ganpat University, North Gujarat, India. He did his Ph.D. from Hemchandracharya North Gujarat University, Patan. He did his PG and UG from M.S.University, Baroda. He has 19 years of experience in academic/industry (17+2). He awarded with Carrier Award for Young Teacher by AICTE, New Delhi in 2013. He also awarded for Distinguished Associate Professor by in TechNExt India 2017 by CSI, Mumbai. He claims on his name more than fifty national and international publication. He fetched grant for Research Projects, Staff Development Programs, Seminars, Conferences and Travel Grants from National and State Government agencies. He is also given his guidance in industrial consultancy projects conducted at institute. His two patents published and one application submitted at Indian Patent office. He had delivered expert talk and invited scientific session in several national and international conference and seminars. He is actively working in the field of lipid-based drug delivery and nanotech formulations. He guided 7 Ph.D. and 45 PG research scholars supervised. 5 Ph.D and 3 PG research scholars are currently working under his guidance in the field of Nanoparticulate Drug Delivery and Bioavailability Enhancement.

Dr. Dinesh K. Badyal is Professor and Head, Department of Pharmacology, Christian Medical College, Ludhiana. He has done his M.B.B.S. from Punjab and M.D. from PGI, Chandigarh. He is a Member of the Reconciliation Board, Medical Council of India; Co-Convener of the Medical Council of India, Nodal Centre for Faculty Development; and Co-Director of the CMCL-FAIMER Regional Institute at CMC, Ludhiana. He also serves as Faculty at the GSMC-FAIMER Regional Institute, Mumbai. Dr. Badyal was awarded a Scholarship by the German Academic Exchange Service; a Prof. G. Achari Oration for Eminent Pharmacologist by the Indian Pharmacology Society; a Rajiv Gandhi Gold Medal Award by the Global Economic Progress & Research Association (GEPRA); an International Fellowship in Medical Education (IFME) by FAIMER; and an ML Gupta award by the Association of Physiologists & Pharmacologists of India. He has published more than 80 papers and authored two books and contributed chapters in others. He is a Member, Core Training Panel, Pharmacovigilance Program of India; and Senior Editor, Indian Journal of Pharmacology. Dr. Badyal is on the editorial board of a number of journals and has delivered a number of lectures on clinical trials, pharmacovigilance, ethics, research methodology, writing manuscripts, kinetics, and medical education at national and international conferences and workshops. He has keen interest in assessment and developed an internal assessment module for undergraduate and postgraduate courses for his university that is being followed in 10 medical colleges of his state. He has also been involved in designing and organizing a number of faculty development programs in India and other countries.

Dr.Kolla Bhanu Prakash is working as Professor and Research Group Head in CSE DEPARTMENT, K L University, VIJAYAWADA, Andhra Pradesh, India. He received his M.Sc and M.Phil in Physics from Acharya Nagarjuna University, Guntur, India, M.E and Ph.D in Computer Science Engineering from Sathyabama University,Chennai, India. Dr.Kolla Bhanu Prakash has 15+ years of experience working in the academia, research, teaching, academic administration. His current research interests include A.I, Deep Learning, Data Science, Smart Grids, Cyber-physical systems, Cryptocurrency, Block-chain technology and Image Processing. Dr.K.Bhanu Prakash is IEEE Senior Member. He is Fellow-ISRD, Treasurer - ACM Amaravathi Chapter, India, LMISTE, MIAENG, SMIRED. He has reviewed more than 130 peer reviewed journals and are indexed in publons. He is editor for 6 books in Elsevier, CRC Press, Springer, Wiley, Degryuter publishers. He published 75 research papers, 7 patents, 1 copyright, 7books + 4 accepted. His scopus H-index is 14. He is a frequent editorial board member and TPC member in flagship conferences and refereed journals. He is reviewer for IEEE Access journal, Springer Nature, Inderscience publisher, Applied Soft Computing Journal – Elsevier, Wireless Networks Journal, IET journals, KSII journal, IEEE Computer Society journals. He is Series Editor – “Next Generation Computing & Communication Engineering” – Wiley publishers; under this series at present 5 books agreement signed. He is series editor - “Industry 5.0: Artificial Intelligence, Cyber-Physical Systems, Mechatronics and Smart Grids” – CRC publishers.